학술논문
LOW-DOSE EMPAGLIFLOZIN AS ADJUNCT TO HYBRID CLOSED-LOOP INSULIN THERAPY IN SUB-OPTIMALLY CONTROLLED ADULTS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER CONTROLLED TRIAL
Document Type
Abstract
Author
Source
In Canadian Journal of Diabetes November 2023 47(7) Supplement:S120-S120
Subject
Language
ISSN
1499-2671